Phase 3 Heart Disease Trial, Recruiting NCT05997693 Sponsor: Weill Medical College of Cornell University Condition: Heart Disease
Back to Heart Disease

Phase 3 Heart Disease Trial, Recruiting

NCT05997693
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You are scheduled for your first heart bypass surgery (CABG) that is planned in advance (not an emergency), and at least one vein from your leg will be used during the surgery
  • You are able to give your consent to participate and are willing and able to attend all follow-up visits for at least 5 years

Who may not be able to join:

  • You have had a recent heart attack or severe chest pain episode within the last year, or recently had a procedure to open blocked arteries (stent/angioplasty) that requires you to stay on two blood-thinning medications after surgery
  • You are currently taking or expected to take blood-thinning medication in pill form (such as warfarin or similar medicines)
  • You have a heart rhythm problem called atrial fibrillation (irregular heartbeat), whether it comes and goes or is permanent
  • You are having any other heart or non-heart procedure at the same time as your bypass surgery
  • You have another heart or non-heart surgery planned within one year
  • You have serious problems with your kidneys (requiring dialysis), liver, or lungs, or you have cancer or another serious illness where life expectancy is less than 5 years
  • The vein in your leg cannot be used for the bypass surgery
  • You have a medical reason why you cannot take aspirin
  • You have a medical reason why you cannot take the medication ticagrelor, including a known allergy to it, active bleeding anywhere in your body, a history of bleeding in the brain, or you are taking certain other medications that interact with it (confirm with trial site for the full list of interacting medications)
  • You are unable to have a special type of heart scan called a coronary CT angiography (a detailed X-ray scan of the heart's blood vessels)
  • You are currently taking part in another clinical trial involving a drug or medical device
  • You are a woman who could become pregnant
  • You experienced a serious complication during or after your bypass surgery, such as a stroke, mini-stroke, heart attack, major bleeding related to the surgery, or a severe infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Registry
ClinicalTrials.gov
Start date
15 August 2024
Est. completion
1 January 2027

Where this trial is recruiting

🇦🇹 Austria 🇨🇦 Canada 🇨🇳 China 🇩🇪 Germany 🇸🇪 Sweden 🇺🇸 United States

Primary endpoints

Hierarchical composite of time to death, stroke, myocardial infarction, repeat revascularization and any graft failure.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov